Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMC 2679434)

Published in J Biol Chem on March 26, 2009

Authors

Taeko Shigemoto1, Maiko Kageyama, Reiko Hirai, Jiping Zheng, Mitsutoshi Yoneyama, Takashi Fujita

Author Affiliations

1: Laboratory of Molecular Genetics, Institute for Virus Research, and Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8507, Japan.

Articles citing this

Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02

Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus. Hepatology (2015) 2.11

Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci U S A (2010) 1.98

Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol (2010) 1.85

Identification and characterization of a loss-of-function human MPYS variant. Genes Immun (2011) 1.60

Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol (2010) 1.43

Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol (2011) 1.38

MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci U S A (2012) 1.37

Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet (2010) 1.32

Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol (2011) 1.31

Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev (2011) 1.22

Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One (2010) 1.18

Pathophysiology and treatment of septic shock in neonates. Clin Perinatol (2010) 1.17

Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet (2015) 1.17

Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol (2010) 1.15

Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS One (2013) 1.11

Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res (2011) 1.07

Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response. PLoS One (2009) 1.07

RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice. J Clin Invest (2011) 1.04

Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev (2012) 1.04

Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol (2016) 1.02

A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J Immunol (2010) 1.01

Translating nucleic acid-sensing pathways into therapies. Nat Rev Immunol (2015) 0.96

Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes (2012) 0.95

Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes. Clin Exp Immunol (2012) 0.94

dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol Rev (2011) 0.93

International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease. Pharmacol Rev (2015) 0.92

The virome in host health and disease. Immunity (2015) 0.92

Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol (2013) 0.91

Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. Structure (2012) 0.90

Study of transcriptional effects in Cis at the IFIH1 locus. PLoS One (2010) 0.90

Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I. J Virol (2014) 0.90

The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites. PLoS Pathog (2016) 0.89

MDA5-filament, dynamics and disease. Curr Opin Virol (2015) 0.88

Infection as a cause of type 1 diabetes? Curr Opin Rheumatol (2012) 0.88

Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol (2010) 0.87

Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Res Ther (2010) 0.86

Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. J Exp Med (2016) 0.86

Ancient origins of vertebrate-specific innate antiviral immunity. Mol Biol Evol (2013) 0.84

C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map. Cancer Manag Res (2012) 0.84

TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. J Leukoc Biol (2011) 0.84

Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5. BMC Biol (2015) 0.82

The genetic basis of graves' disease. Curr Genomics (2011) 0.81

Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity. PLoS One (2011) 0.79

Enterovirus RNA in peripheral blood may be associated with the variants of rs1990760, a common type 1 diabetes associated polymorphism in IFIH1. PLoS One (2012) 0.78

Virus infections as potential targets of preventive treatments for type 1 diabetes. Rev Diabet Stud (2012) 0.77

Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6. EBioMedicine (2016) 0.77

A Critical Role for the Type I Interferon Receptor in Virus-Induced Autoimmune Diabetes in Rats. Diabetes (2016) 0.76

Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency. Nat Genet (2016) 0.75

Alteration of Antiviral Signalling by Single Nucleotide Polymorphisms (SNPs) of Mitochondrial Antiviral Signalling Protein (MAVS). PLoS One (2016) 0.75

An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets. Sci Rep (2016) 0.75

No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis. J Neuroimmunol (2010) 0.75

Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset. Front Endocrinol (Lausanne) (2017) 0.75

Discrimination of Cytosolic Self and Non-Self RNA by RIG-I-like Receptors. J Biol Chem (2017) 0.75

A rare coding allele in IFIH1 is protective for psoriatic arthritis. Ann Rheum Dis (2017) 0.75

Articles cited by this

Pathogen recognition and innate immunity. Cell (2006) 44.14

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science (2009) 16.35

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00

5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78

Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol (2005) 9.17

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 9.00

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 8.87

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet (2006) 8.65

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A (2006) 8.27

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A (2006) 5.70

The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell (2008) 5.35

Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell (2008) 5.20

Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity (2008) 2.81

The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J Biol Chem (2009) 1.78

Articles by these authors

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65

Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 9.37

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol (2005) 9.17

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol (2005) 9.11

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 9.00

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A (2006) 5.70

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A (2005) 5.64

The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell (2008) 5.35

Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell (2008) 5.20

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A (2006) 4.84

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature (2002) 4.81

RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev (2009) 4.41

A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol (2006) 3.46

Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev (2004) 3.33

LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A (2010) 2.90

Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A (2007) 2.88

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol (2006) 2.85

Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity (2008) 2.81

NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol (2006) 2.78

Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem (2007) 2.74

Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol (2007) 2.73

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem (2003) 2.61

RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev (2011) 2.48

Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J Biol Chem (2003) 2.45

Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem (2007) 2.40

Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res (2002) 2.39

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum (2009) 2.37

Recognition of viral nucleic acids in innate immunity. Rev Med Virol (2010) 2.33

Relieving anxiety by entering the operating room on foot. Can J Anaesth (2002) 2.14

The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol (2005) 2.13

RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev (2007) 1.94

X-ray crystal structure of IRF-3 and its functional implications. Nat Struct Biol (2003) 1.88

Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet (2002) 1.83

Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog (2010) 1.82

Green light drives leaf photosynthesis more efficiently than red light in strong white light: revisiting the enigmatic question of why leaves are green. Plant Cell Physiol (2009) 1.75

Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol (2005) 1.72

A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol (2002) 1.70

Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J Biol Chem (2009) 1.68

Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog (2010) 1.66

A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol (2005) 1.63

Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn (2007) 1.56

Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One (2012) 1.55

NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol (2006) 1.54

Effect of warm ischemia on renal function during partial nephrectomy: assessment with new 99mTc-mercaptoacetyltriglycine scintigraphy parameter. Urology (2011) 1.54

The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism (2008) 1.50

Prediction of partial nephrectomy outcomes by using the diameter-axis-polar nephrometry score. Int J Urol (2013) 1.42

Triggering antiviral response by RIG-I-related RNA helicases. Biochimie (2007) 1.37

Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J Biol Chem (2002) 1.32

Cytoplasmic nucleic acid sensors in antiviral immunity. Trends Mol Med (2009) 1.15

Intra-leaf gradients of photoinhibition induced by different color lights: implications for the dual mechanisms of photoinhibition and for the application of conventional chlorophyll fluorometers. New Phytol (2011) 1.15

Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol (2013) 1.13

RIG-I activation inhibits ebolavirus replication. Virology (2009) 1.12

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol (2012) 1.11

Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther (2011) 1.09

Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev Biol (2006) 1.08

Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination. J Biol Chem (2003) 1.07

Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology (2013) 1.03

Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol (2009) 1.03

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J (2010) 1.02

HxlR, a member of the DUF24 protein family, is a DNA-binding protein that acts as a positive regulator of the formaldehyde-inducible hxlAB operon in Bacillus subtilis. Mol Microbiol (2005) 1.02

Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Genes Cells (2010) 1.01

Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner Res (2006) 1.01

Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J Virol (2006) 0.99

IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J Immunol (2003) 0.99

Complete nucleotide sequence and construction of an infectious clone of Chinese yam necrotic mosaic virus suggest that macluraviruses have the smallest genome among members of the family Potyviridae. Arch Virol (2012) 0.99

Retinoic acid-inducible gene-I-like receptors. J Interferon Cytokine Res (2010) 0.98

High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation (2005) 0.98

Type I interferon production induced by RIG-I-like receptors. J Interferon Cytokine Res (2010) 0.98

The ribulose monophosphate pathway operon encoding formaldehyde fixation in a thermotolerant methylotroph, Bacillus brevis S1. FEMS Microbiol Lett (2002) 0.98

Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. PLoS One (2011) 0.98

Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett (2002) 0.97

Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model. Eur J Cancer (2008) 0.97